[go: up one dir, main page]

GT200900060A - Procedimiento de preparación de halogenuros de n-alquil-naltrexona - Google Patents

Procedimiento de preparación de halogenuros de n-alquil-naltrexona

Info

Publication number
GT200900060A
GT200900060A GT200900060A GT200900060A GT200900060A GT 200900060 A GT200900060 A GT 200900060A GT 200900060 A GT200900060 A GT 200900060A GT 200900060 A GT200900060 A GT 200900060A GT 200900060 A GT200900060 A GT 200900060A
Authority
GT
Guatemala
Prior art keywords
carbonate
methyl
preparation procedure
naltrexona
halogenure
Prior art date
Application number
GT200900060A
Other languages
English (en)
Inventor
Alain Dlubala
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200900060A publication Critical patent/GT200900060A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCIÓN SE REFIERE A UN NUEVO PROCEDIMIENTO DE PREPARACIÓN DEL BROMURO DE N-METIL-NALTREXONA, QUE COMPRENDE AL MENOS LAS ETAPAS QUE CONSISTEN EN: (I) HACER REACCIONAR EL METILSULFATO DE N-METIL-NALTREXONA EN SOLUCIÓN ACUOSA CON UN AGENTE ALCALINO ELEGIDO DEL GRUPO CONSTITUIDO POR CARBONATO DE SODIO, CARBONATO DE POTASIO, CARBONATO DE CALCIO, CARBONATO DE MAGNESIO, CARBONATO DE CESIO, CARBONATO DE ESTRONCIO Y LAS MEZCLAS DE ESTOS, PARA UN PH DEL MEDIO DE REACCIÓN ACUOSO COMPRENDIDO ENTRE 7 Y 10, Y DESPUÉS (II) HACER REACCIONAR EL PRODUCTO ASÍ OBTENIDO CON EL ÁCIDO BROMHÍDRICO QUE SE AÑADE, PARA UN PH DEL MEDIO DE REACCIÓN ACUOSO COMPRENDIDO ENTRE 5,5 Y 5 Y OBTENER ASÍ EL BROMURO DE N-METIL-NALTREXONA.
GT200900060A 2006-09-21 2009-03-12 Procedimiento de preparación de halogenuros de n-alquil-naltrexona GT200900060A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0608286A FR2906252B1 (fr) 2006-09-21 2006-09-21 Procede de preparation d'halogenures de n-aklyl naltrexone

Publications (1)

Publication Number Publication Date
GT200900060A true GT200900060A (es) 2011-01-04

Family

ID=38016779

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200900060A GT200900060A (es) 2006-09-21 2009-03-12 Procedimiento de preparación de halogenuros de n-alquil-naltrexona

Country Status (36)

Country Link
US (2) US7645880B2 (es)
EP (1) EP2069362B1 (es)
JP (1) JP5214615B2 (es)
KR (1) KR101434693B1 (es)
CN (2) CN101516892B (es)
AR (1) AR062918A1 (es)
AU (1) AU2007298855B2 (es)
BR (1) BRPI0718440A2 (es)
CA (1) CA2663509C (es)
CL (1) CL2007002711A1 (es)
CO (1) CO6170362A2 (es)
CR (1) CR10660A (es)
DO (1) DOP2011000307A (es)
EA (1) EA015426B1 (es)
ES (1) ES2531093T3 (es)
FR (1) FR2906252B1 (es)
GT (1) GT200900060A (es)
HK (1) HK1135389A1 (es)
HN (1) HN2009000503A (es)
IL (1) IL197402A (es)
JO (1) JO3023B1 (es)
MA (1) MA30793B1 (es)
ME (1) MEP10509A (es)
MX (1) MX2009003084A (es)
MY (1) MY148094A (es)
NI (1) NI200900035A (es)
NO (1) NO20091561L (es)
NZ (1) NZ575417A (es)
PE (1) PE20080867A1 (es)
SV (1) SV2009003192A (es)
TN (1) TN2009000080A1 (es)
TW (1) TWI465451B (es)
UA (1) UA96957C2 (es)
UY (1) UY30599A1 (es)
WO (1) WO2008034973A1 (es)
ZA (1) ZA200901846B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010522756A (ja) 2007-03-29 2010-07-08 プロジェニックス ファーマシューティカルズ，インコーポレーテッド 結晶形およびその使用
WO2008138383A1 (de) 2007-05-16 2008-11-20 Cilag Ag Verfahren zur herstellung von n-methylnaltrexonbromid
US8383649B2 (en) * 2007-07-11 2013-02-26 Mallinckrodt Llc Crystalline forms of naltrexone methobromide
EP2019105A1 (en) * 2007-07-19 2009-01-28 Siegfried Ltd. Process for the preparation of quaternary n-alkyl morphine or morphinane alkaloid derivatives
ES2566559T3 (es) * 2008-09-30 2016-04-13 Mallinckrodt Llc Procesos para la alquilación de grupos amino secundarios de derivados de morfinano
US8436174B2 (en) * 2009-02-23 2013-05-07 Mallinckrodt Llc (+)-morphinanium quaternary salts and processes for their production
EP2398807A1 (en) * 2009-02-23 2011-12-28 Mallinckrodt LLC (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
US8563727B2 (en) * 2009-02-23 2013-10-22 Mallinckrodt Llc (+)-morphinanium N-oxides and processes for their production
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
CN102459275A (zh) 2009-04-24 2012-05-16 布鲁克大学 制备吗啡烷和吗啡酮化合物的方法
WO2011009020A2 (en) 2009-07-16 2011-01-20 Mallinckrodt Inc. Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
CN101845047B (zh) * 2009-12-31 2011-12-07 南京臣功制药有限公司 一种溴甲基纳曲酮的制备方法
JO3209B1 (ar) * 2010-11-05 2018-03-08 H Lundbeck As طريقة لتصنيع نالتريكسون
US8580963B2 (en) 2010-11-05 2013-11-12 H. Lundbeck A/S Method for the manufacturing of naltrexone
PL2635586T3 (pl) 2010-11-05 2017-06-30 H. Lundbeck A/S Sposób wytwarzania naltreksonu
US9029543B2 (en) 2011-04-05 2015-05-12 Alkermes, Inc. Process for the synthesis of quaternary amine compounds
PL2753622T3 (pl) 2011-09-08 2016-07-29 SpecGx LLC Wytwarzanie alkaloidów bez oddzielania związków pośrednich
CN103172640A (zh) * 2011-12-22 2013-06-26 天津康鸿医药科技发展有限公司 一种(r)-n-溴甲基纳曲酮的制备方法以及纳曲酮衍生物
AR090916A1 (es) 2012-05-03 2014-12-17 Lundbeck & Co As H Metodo para la fabricacion de naltrexona
CN105985348B (zh) * 2015-02-12 2019-02-01 正大天晴药业集团股份有限公司 一种溴甲基纳曲酮的制备方法
CN106317064B (zh) * 2015-06-30 2018-06-19 北大方正集团有限公司 溴甲纳曲酮的制备方法
KR102201609B1 (ko) * 2019-04-19 2021-01-12 연성정밀화학(주) 날데메딘의 제조방법
CN111777617A (zh) * 2020-07-10 2020-10-16 华润三九医药股份有限公司 一种溴甲纳曲酮的精制方法
CA3194746A1 (en) 2020-10-06 2022-04-14 Tien-Li Lee Oral delayed burst formulation of low-dose naltrexone or naloxone used for|treating fibromyalgia and long covid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4176186A (en) * 1978-07-28 1979-11-27 Boehringer Ingelheim Gmbh Quaternary derivatives of noroxymorphone which relieve intestinal immobility
EP1562953B1 (en) * 2002-11-08 2009-09-30 Mallinckrodt Inc. Process for the preparation of quaternary n-alkyl morphinan alkaloid salts
AR057325A1 (es) * 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos

Also Published As

Publication number Publication date
TN2009000080A1 (en) 2010-08-19
TWI465451B (zh) 2014-12-21
WO2008034973A1 (fr) 2008-03-27
US20100145051A1 (en) 2010-06-10
AU2007298855A1 (en) 2008-03-27
SV2009003192A (es) 2009-10-27
CR10660A (es) 2009-06-24
ME00613B (me) 2011-12-20
MX2009003084A (es) 2009-04-02
MA30793B1 (fr) 2009-10-01
IL197402A0 (en) 2009-12-24
BRPI0718440A2 (pt) 2013-11-19
UY30599A1 (es) 2008-05-02
ZA200901846B (en) 2010-07-28
NZ575417A (en) 2011-09-30
DOP2011000307A (es) 2011-10-31
CA2663509C (fr) 2014-03-18
UA96957C2 (ru) 2011-12-26
PE20080867A1 (es) 2008-08-22
HN2009000503A (es) 2011-03-02
EA015426B1 (ru) 2011-08-30
IL197402A (en) 2012-12-31
NI200900035A (es) 2010-01-26
CA2663509A1 (fr) 2008-03-27
TW200821314A (en) 2008-05-16
CN101516892A (zh) 2009-08-26
HK1135389A1 (en) 2010-06-04
JP2010504308A (ja) 2010-02-12
CN101516892B (zh) 2012-06-20
JP5214615B2 (ja) 2013-06-19
NO20091561L (no) 2009-06-16
JO3023B1 (ar) 2016-09-05
KR20090057031A (ko) 2009-06-03
US8288547B2 (en) 2012-10-16
AU2007298855B2 (en) 2012-09-13
EP2069362A1 (fr) 2009-06-17
US20080214817A1 (en) 2008-09-04
ES2531093T3 (es) 2015-03-10
EA200970307A1 (ru) 2009-12-30
US7645880B2 (en) 2010-01-12
AR062918A1 (es) 2008-12-17
KR101434693B1 (ko) 2014-08-27
FR2906252A1 (fr) 2008-03-28
CL2007002711A1 (es) 2008-04-18
FR2906252B1 (fr) 2008-11-28
CN102225939A (zh) 2011-10-26
CO6170362A2 (es) 2010-06-18
MY148094A (en) 2013-02-28
MEP10509A (en) 2011-12-20
EP2069362B1 (fr) 2014-07-09

Similar Documents

Publication Publication Date Title
GT200900060A (es) Procedimiento de preparación de halogenuros de n-alquil-naltrexona
ES2555989T3 (es) Procedimiento para la síntesis del ácido 2,5-furanodicarboxílico
BR112012027444A2 (pt) bloco cáustico altamente concentrado para lavagem de louças
MX2009013255A (es) Matriz de solidificacion que incluye una sal de un acido mono-, di- o tri-carboxilico saturado de cadena recta.
BRPI0806702A8 (pt) cimento de alta resistência, argamassa e concreto incluindo subprodutos industrias
EA200702549A1 (ru) Способ производства органического соединения
DE602007008851D1 (de) Ektionsmittel
CR8879A (es) Bifeniltiazolcarboxamidas
BR112013033388A2 (pt) composição cimentícia e mistura
PE20100011A1 (es) Combinacion biocida para utilizacion en aplicaciones agricolas
CO5670371A2 (es) Composiciones limpiadoras en la forma de una tableta
DK2262751T3 (da) Anvendelse af alkalsulfonsyre som rengøringsmiddel til cement, mørtel og beton
MX2009012170A (es) Tinte de concreto basado en acido debil.
AR064658A1 (es) Proceso para preparar duloxetina y sus compuestos relacionados, asi como tambien intermediarios utiles en la misma
TW200833371A (en) Process for solid formulations
EA201490360A1 (ru) Композиции, содержащие соли аминокислот
CL2011002278A1 (es) Proceso para la preparacion de (e)-n-(4-(3-ter-butil-5-(2,4-dioxo-3,4-dihidropirimidin-1(2h)-il)-2-metoxiestiril)fenil)metansulfonamida o su sal por reduccion del correspondiente etinilo; y los compuestos intermediarios considerados.
WO2008107463A3 (en) Solid detergent composition and process to prepare the same
CR9424A (es) Ibuprofeno solubilizado
DOP2009000041A (es) Procedimiento de preparacion de halogenuros de n-alquil-naltrexona
BRPI0516335A (pt) composição de limpeza lìquida/gel e processo para a preparação de uma composição de limpeza lìquida/gel
EP3593650A3 (en) Preparations capable of increasing the ph of food by releasing molecular hydrogen
WO2007129184A3 (en) An improved process for the preparation of phenytoin sodium
AR071540A1 (es) Proceso para la produccion de un compuesto de toluidina
PL396849A1 (pl) Sposób wytwarzania materialu izolacyjnego ognioodpornego